Would you like to leave a message? https://www.ukmeds.co.uk/ciprofloxacin The diversified manufacturer, which is in the middle of arestructuring of its sprawling operations, reportedsecond-quarter earnings per share from continuing operationsof $464 million, or $1.03, down from $519 million, or $1.09 ashare, a year before.
|